EUVIMEDEUVIMED entdecken
Crossref

Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET

Paula Nogales iD, Carlos Velasco iD, Leticia González-Cintado iD, Diana Sharysh iD, Adriana Mota-Cobián iD, Raúl Izquierdo-Serrano iD, Carlos Torroja iD, David Del Rio-Aledo iD, Daniel Morales-Cano iD, Rubén A Mota iD, Alberto Benguría iD, Ana Dopazo iD und 6 weitere

Science Translational Medicine · 2025

DOI: 10.1126/scitranslmed.ado6467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Paula Nogales und 17 weiteren Autor:innen. Beteiligte Einrichtung: Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid 28029, Spain. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron-Emission Tomography, Atherosclerosis, Glycolysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Positron emission tomography (PET) imaging with the radiolabeled glucose analog fluorodeoxyglucose ( 18 FDG) is used to monitor atherosclerosis in clinical trials, but there is uncertainty regarding the plaque cell types that accumulate FDG and how uptake is regulated. The long-standing view that 18 FDG is mainly taken up by macrophages is at odds with human and experimental data, and the impact of disease activity on 18 FDG uptake has not been examined directly. To analyze the ability of 18 FDG-PET to monitor disease activity, we developed a model of plaque regression in minipigs with hepatic overexpression of a gain-of-function mutant of proprotein convertase subtilisin/kexin type 9 ( PCSK9 ). Atherosclerosis was induced through 12 months of high-fat feeding in the porcine model. Disease activity was then lowered for 3 months by reducing plasma cholesterol with a low-fat diet alone or in combination with the microsomal transfer protein (MTP) inhibitor BMS-212122. Plaque regression in advanced lesions of the abdominal aorta was evident from reduced lipid content, reduced necrotic core size, and partial resolution of plaque inflammation and was accompanied by a decline in 18 FDG-PET signal. Single-cell gene expression profiling revealed that plaque regression involved substantial down-regulation of genes encoding glycolytic enzymes in smooth muscle cells (SMCs), macrophages, and lymphocytes, which was corroborated by analysis of the plaque cellular proteome. These findings in a large-animal model suggest that 18 FDG-PET can monitor atherosclerosis because of a close association between disease activity and glycolytic enzyme expression in all of the major plaque cell types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Positron-Emission TomographyAtherosclerosisGlycolysisAnimalsSwineSwine, MiniaturePlaque, AtheroscleroticProprotein Convertase 9Humans

Substanzen

Fluorodeoxyglucose F18Proprotein Convertase 9

Autor:innen und Institutionen

  • Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid 28029, Spain.
  • Department of Clinical Medicine, Aarhus University, Aarhus 8200, Denmark.
  • Universidad Complutense de Madrid, Madrid 28040, Spain.
  • Universidad Europea de Madrid SLU, Villaviciosa de Odón 28670, Spain.
  • CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid 28029, Spain.
  • Instituto de Tecnologías Físicas y de la Información Leonardo Torres Quevedo, Consejo Superior de Investigaciones Científicas, Madrid 28006, Spain.

ORCID-Profile: Paula Nogales, Carlos Velasco, Leticia González-Cintado, Diana Sharysh, Adriana Mota-Cobián, Raúl Izquierdo-Serrano, Carlos Torroja, David Del Rio-Aledo, Daniel Morales-Cano, Rubén A Mota, Alberto Benguría, Ana Dopazo, Jesús Vázquez, Samuel España, Laura Carramolino, Jesús Mateo, Jacob F Bentzon

Zitieren

APA

Nogales, P., Velasco, C., González-Cintado, L., Sharysh, D., Mota-Cobián, A., Izquierdo-Serrano, R., Torroja, C., Del Rio-Aledo, D., Morales-Cano, D., Mota, R. A., Benguría, A., Dopazo, A., Sánchez-Cabo, F., Vázquez, J., España, S., Carramolino, L., Mateo, J., & Bentzon, J. F. (2025). Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ado6467

Vancouver

Nogales P, Velasco C, González-Cintado L, Sharysh D, Mota-Cobián A, Izquierdo-Serrano R, et al. Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.ado6467

BibTeX
@article{Nogales2025,
  author = {Nogales, Paula and Velasco, Carlos and González-Cintado, Leticia and Sharysh, Diana and Mota-Cobián, Adriana and Izquierdo-Serrano, Raúl and Torroja, Carlos and Del Rio-Aledo, David and Morales-Cano, Daniel and Mota, Rubén A and Benguría, Alberto and Dopazo, Ana and Sánchez-Cabo, Fátima and Vázquez, Jesús and España, Samuel and Carramolino, Laura and Mateo, Jesús and Bentzon, Jacob F},
  title = {Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET},
  journal = {Science Translational Medicine},
  year = {2025},
  doi = {10.1126/scitranslmed.ado6467}
}
Kostenlos starten →